शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ANDHRAPAPNSEANDHRA PAPER LIMITED· Paper Forest & Jute ProductsHighNeutral
Announced Wed, 12 Aug, 2026 · 17:27 IST

Andhra Paper MD Saurabh Bangur reappointed for 5 years

ANDHRAPAP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.9%Reaction day
₹59.36
prior close
₹59.84
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+1.8% vs market
Paper & Paper Products peers, median of 38sector-0.9%+2.8% vs sector

On the reaction day the stock moved 1.8 pts more than Nifty Microcap 250 and 2.8 pts more than its Paper & Paper Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
-0.1
15m
-0.1
30m
-0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.9+0.2+1.8-0.9+2.8
Next day
+1.0+0.2+0.8-2.0+3.0
2d
+1.1+0.4+0.7-1.9+2.9
3d
+3.6+0.7+2.9-1.0+4.6
4d
+2.8+0.1+2.6-2.6+5.4
5d
+2.3+0.7+1.7-2.0+4.3
1w
+2.5+1.2+1.3-1.8+4.3
15d
+7.4+0.7+6.7-0.4+7.8
1m
+19.6-1.2+20.8+1.5+18.1
2m
+21.3-1.1+22.4+0.0+21.3
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Paper & Paper Products peers, median of 38Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shareholders at the 62nd AGM on August 11, 2026 approved the re-appointment of Mr. Saurabh Bangur as Managing Director for 5 years effective October 1, 2026. His current term ends September 30, 2026. He is not debarred by SEBI. He is son of Mr. Shree Kumar Bangur and brother of Mr. Virendraa Bangur. He is currently leading the Tissue Machine Project.

Likely market impact

Top-level continuity. Promoter family-led management stays, with ongoing focus on the Tissue Machine Project and diversification plans.